Implementation of Mind-Body Practices in an Online Community of Caring (CaringBridge)
NCT ID: NCT05002842
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
979 participants
INTERVENTIONAL
2018-05-01
2018-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy
NCT01601548
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
NCT05676255
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
NCT02067351
Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers
NCT03528863
LUNGevity: Lung Cancer Stigma Community Based Participatory Research
NCT06286592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate Intervention
Those in the immediate intervention arm will begin the LovingKindess Meditation practice upon enrollment.
LovingKindess Meditation
Participants will have access to a recording of a script to guide them through meditation
Delayed Intervention
Those in the deferred intervention arm will commence the LovingKindness Meditation practice intervention approximately 3 weeks (post 3 -week survey) after enrollment and participate three weeks thereafter.
LovingKindess Meditation
Participants will have access to a recording of a script to guide them through meditation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LovingKindess Meditation
Participants will have access to a recording of a script to guide them through meditation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CaringBridge user with an active email address
* Visitor/Caregiver/Patient on a Cancer Journey (for Phase 2 only)
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Jo Kreitzer, PhD, RN, FAAN
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota Earl E. Bakken Center for Spirituality & Healing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Telke S, Leininger B, Hanson L, Kreitzer MJ. A Randomized Trial of 21 Days of Loving Kindness Meditation for Stress Reduction and Emotional Well-being Within an Online Health Community for Patients, Family, and Friends Experiencing a Cancer Health Journey. J Integr Complement Med. 2022 Feb;28(2):158-167. doi: 10.1089/jicm.2020.0512. Epub 2022 Jan 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1703S09842
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.